⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1266740 | 1.00 | — | — | |
| SCHEMBL2644164 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL15192972 | 0.98 | KDM4E (0.48) | — | |
| Hydrochloric Acid SCHEMBL1266559 | 0.98 | KDM4E (0.48) | — | |
| Hydrochloric Acid SCHEMBL15192970 | 0.98 | KDM4E (0.48) | — | |
| SCHEMBL20833338 | 0.93 | KDM4E (0.40) | — | |
| SCHEMBL16448784 | 0.93 | KDM4E (0.40) | — | |
| SCHEMBL22102118 | 0.87 | — | — | |
| SCHEMBL6299912 | 0.87 | — | — | |
| SCHEMBL6299911 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3694864-B1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA INC (US) | 2025-03-05 | — | — | EP | claimed |
| US-11286270-B2 | Boronic acid derivatives and synthesis thereof | QPEX BIOPHARMA, INC. (US) | 2022-03-29 | — | — | US | claimed |
| US-20200407373-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA, INC. | 2020-12-31 | — | — | US | claimed |
| EP-3694864-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | Qpex Biopharma, Inc. (US) | 2020-08-19 | — | — | EP | claimed |
| WO-2019075084-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA, INC. (US) | 2019-04-18 | — | — | WO | claimed |
| US-7771620-B2 | Polyelectrolyte composition for humidity senser, polyelectrolyte ink and preparation method of poly electrolyte membrane for sensor by inkjet printing | Haeun Chemtec Co., Ltd (KR) | 2010-08-10 | — | — | US | claimed |
| EP-1664167-B1 | THE POLYELECTROLYTE COMPOSITION FOR HUMIDITY SENSOR, POLYELECTROLYTE INK AND PREPARATION METHOD OF POLYELECTROLYTE MEMBRANE FOR SENSOR BY INKJET PRINTING | HAEUN CHEMTEC CO LTD (KR) | 2008-12-10 | — | — | EP | claimed |
| US-20070182791-A1 | Polyelectrolyte composition for humidity senser, polyelectrolyte ink and preparation method of poly electrolyte membrane for sensor by inkjet printing | HAEUN CHEMTEC CO., LTD. (KR) | 2007-08-09 | — | — | US | claimed |
| US-20260042753-A1 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | MERCK PATENT GMBH (DE) | 2026-02-12 | — | — | US | disclosed |
| US-12486260-B2 | Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer | MERCK PATENT GMBH (DE) | 2025-12-02 | — | — | US | disclosed |
| WO-2025217212-A1 | MAC1 INHIBITORS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-16 | — | — | WO | disclosed |
| EP-4520326-A2 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | Merck Patent GmbH (DE) | 2025-03-12 | — | — | EP | disclosed |
| EP-3694864-B1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA INC (US) | 2025-03-05 | — | — | EP | disclosed |
| EP-3924340-B1 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | MERCK PATENT GMBH (DE) | 2025-01-29 | — | — | EP | disclosed |
| EP-1287001-A1 | THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS | Pfizer Products Inc. (US) | 2003-03-05 | — | — | EP | disclosed |
| US-20020042409-A1 | Thiophene derivatives useful as anticancer agents | PFIZER PRODUCTS INC. | 2002-04-11 | — | — | US | disclosed |
| WO-2001094353-A1 | THIOPHENE DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PRODUCTS INC. (US) | 2001-12-13 | — | — | WO | disclosed |
| EP-0844000-A1 | Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis | SANKYO COMPANY LIMITED (JP) | 1998-05-27 | — | — | EP | disclosed |
| US-5556864-A | TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0600717-A1 | Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis | SANKYO COMPANY LIMITED (JP) | 1994-06-08 | — | — | EP | disclosed |